208175-71-7

Basic information

• Product Name: ethyl 4-(quinoline-8-sulfonamido)benzoate
• Synonyms: ethyl 4-(quinoline-8-sulfonamido)benzoate
• CAS NO: 208175-71-7
• Molecular Weight: 356.402
• Mol File: 208175-71-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: ethyl 4-(quinoline-8-sulfonamido)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(quinoline-8-sulfonamido)benzoate(208175-71-7)
• EPA Substance Registry System: ethyl 4-(quinoline-8-sulfonamido)benzoate(208175-71-7)

Safety Data

• Hazardous Substances Data: 208175-71-7(Hazardous Substances Data)

Upstream product

• 18704-37-5 quinoline-8-sulfonyl chloride 
• 94-09-7 p-aminoethylbenzoate 

Downstream Products

• 1383372-42-6 N-(4-(3-(benzylamino)azetidine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1383372-04-0 N-(4-(3-(benzyloxy)azetidine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1383372-34-6 N-(4-(3-(3-allylureido)azetidine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1383371-97-8 N-(4-(3-benzyl-3-hydroxyazetidine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1384447-28-2 C₂₈H₂₇N₅O₄S 
• 1260078-20-3 N-(4-(4-(4-fluorobenzyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1384444-80-7 (S)-N-(4-(4-(1-phenylethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1384448-88-7 C₂₂H₂₄N₄O₃S 
• 1384446-78-9 N-(4-(4-(1,2,3-thiadiazole-5-carbonyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1384445-25-3 N-(4-(4-((1H-pyrazol-3-yl)methyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide 
• 1384445-22-0 N-(4-(4-(3,5-difluorobenzyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide-(D₂) 
• 1384445-20-8 N-(4-(4-(4-fluorobenzyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide-(D) 
• 1384447-30-6 (2S,6R)-ethyl 2,6-dimethyl-4-(4-(quinoline-8-sulfonamido)benzoyl)piperazine-1-carboxylate 
• 1384445-23-1 N-(4-(4-(2-methoxyphenyl)-2-methylpiperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide 

Relevant articles and documents

CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL) PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE

Provided herein are amorphous and crystalline hemisulfate salt forms of the formula (I). Also provided are pharmaceutical compositions comprising the amorphous and crystalline hemisulfate salt forms, methods for their manufacture, and uses thereof for tre

Pyruvate kinase activators for use in therapy

Described herein are methods for using compounds that activate pyruvate kinase.

NOVEL N- (4- (AZETIDINE - 1 - CARBONYL) PHENYL) - (HETERO - ) ARYLSULFONAMIDE DERIVATIVES AS PYRUVATE KINASE M2 (PMK2) MODULATORS

Compounds of general Formula (I), and compositions comprising compounds of general formula I that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of canc